ACRO Biomedical Co., Ltd. carries a market capitalization of 12.78B, placing it among publicly traded companies globally.
| Market Cap | 12.78B |
| Enterprise Value | N/A |
ACRO Biomedical Co., Ltd.'s stock has gained approximately 356.16264% over the past 52 weeks. The 50-day moving average sits at 98.63, while the 200-day moving average is 73.55.
| Beta (5Y) | N/A |
| 52-Week Price Change | 356.16264% |
| 50-Day Moving Average | 98.63 |
| 200-Day Moving Average | 73.55 |
| Average Volume (20 Days) | N/A |
ACRO Biomedical Co., Ltd.'s most recent stock split took place on February 8, 2022 with a 50:53 split ratio.
| Last Split Date | 2/8/2022 |
| Split Ratio | 50:53 |